Gene Expression Market Forecast Highlights Expansion From $14.15 Billion To $22.22 Billion Through 2030
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Gene Expression Market Size Outlook: How Fast Will Revenue Grow Through 2030?
The market for gene expression experienced significant expansion over the last few years, increasing from $12.67 billion in 2025 to $14.16 billion in 2026, representing a compound annual growth rate (CAGR) of 11.7%. This historical growth was driven by several factors, including higher funding for academic genomics research, a growing frequency of chronic and genetic disorders, the early implementation of microarray technologies, the widening of pharmaceutical research and development pipelines, and the increased utilization of PCR-based methods.
The gene expression market is anticipated to experience substantial growth over the coming years. By 2030, it is projected to reach a valuation of $22.22 billion, driven by a compound annual growth rate (CAGR) of 11.9%. This upward trajectory in the forecast period is fueled by progress in RNA sequencing technologies, a heightened emphasis on precision medicine, the expansion of clinical diagnostic applications, the incorporation of artificial intelligence into gene expression data analysis, and growing investments within the biotechnology sector. Key developments shaping the forecast period involve the broadening scope of single-cell gene expression analysis, the rising application of spatial transcriptomics, the escalating need for high-throughput PCR platforms, an increased uptake of multi-omics integration, and the establishment of standardized gene expression workflows.
Download A Free Sample Report For Comprehensive Market Insights:
Gene Expression Market Demand Drivers: What Is Fueling Industry Growth?
The increasing prevalence of chronic illnesses is anticipated to boost the gene expression market in the coming years. Chronic diseases are extended medical conditions that last for a lengthy duration, typically three months or more. Gene expression analysis is applied to such diseases to decipher the molecular processes behind them, detect possible biomarkers, and create targeted treatments. For example, in June 2024, the National Health Service, a UK government agency, reported that 3,615,330 patients registered with a general practitioner were identified with non-diabetic hyperglycemia or pre-diabetes—a condition characterized by high blood sugar levels that do not yet meet diabetes criteria—in 2023. This figure reflects an 18% rise compared to 3,065,825 cases documented in 2022. Consequently, the growing incidence of chronic diseases is set to fuel the expansion of the gene expression market.
Gene Expression Market Segmentation Trends And Revenue Drivers
The gene expression market covered in this report is segmented –
1) By Product: Kits And Reagents, DNA Chip Or Microarray, Other Products
2) By Process: Sample Collection, Purification, cDNA Synthesis And Conversion, PCR Analysis, Data Analysis And Interpretation
3) By Technique: RNA Exp, Promoter Analysis, Protein Exp. And Posttranslational Modification Analysis
4) By Application: Drug Discovery And Development, Clinical Diagnostics, Biotechnology And Microbiology, Other Applications
Subsegments:
1) By Kits And Reagents: RNA Isolation Kits, cDNA Synthesis Kits, qPCR Kits, Reverse Transcription Kits, Other Reagents
2) By DNA Chip Or Microarray: Expression Microarrays, Genotyping Microarrays, Comparative Genomic Hybridization Arrays
3) By Other Products: Software For Data Analysis, Lab Instruments, Consumables
Gene Expression Market Innovation Trends: Which Developments Are Transforming The Industry?
Major industry players in the gene expression space are concentrating on creating cutting-edge products like gene detection assays to secure a market edge and boost their earnings. A gene detection assay within gene expression refers to a technique used to identify and measure the presence of genetic molecules, offering clarity on the activity and abundance of particular genes. In January 2023, for example, Bio-Techne Corporation, a biotech firm headquartered in the US that specializes in research instruments, broadened its Advanced Cell Diagnostics (ACD) branded RNAscope in situ hybridization (ISH) lineup by unveiling the RNAscope Plus smRNA-RNA detection assay. This novel assay enables the simultaneous fluorescent detection of a small regulatory RNA along with three target RNAs or RNA biomarkers within a single tissue section, achieving resolution at the single-cell and subcellular level. Created to support large-scale studies, the assay works seamlessly with the Leica Bond Rx platform and is also offered as a manual assay for ease of use. Such therapeutic nucleic acids hold the capacity to alter the expression and function of specific target genes, paving the way for the development of personalized treatments for inherited or acquired diseases that have resisted conventional approaches.
Gene Expression Market Industry Leaders: Which Organizations Are Driving Competition?
Major companies operating in the gene expression market are Thermo Fisher Scientific Inc., Qiagen NV, Illumina Inc., Bio-Rad Laboratories Inc., Agilent Technologies Inc., PerkinElmer Inc., GE Healthcare, F Hoffmann-La Roche Ltd, Oxford Gene Technology IP Limited, Promega Corporation, OriGene Technologies Inc., Luminex Corporation, Takara Bio Inc., Danaher Corporation, ELITechGroup, Biocartis Group NV, Integragen SA, Oxford Nanopore Technologies Limited, Phalanx Biotech Group, Roche Holding AG, Sengenics Corporation Pte Ltd., GenXPro GmbH, Twist Bioscience Corporation, Zymo Research Corporation, Abcam plc., Bio-Techne Corporation
Access The Complete Gene Expression Market Report:
Gene Expression Market Largest Region By Revenue And Market Share
North America was the largest region in the gene expression market in 2025. Asia-Pacific is expected to be the fastest-growing region in the gene expression market in the forecast period. The regions covered in the gene expression market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
